Efficacy of rehabilitation for patients with ankylosing spondylitis: Comparison of a four-week rehabilitation programme in a Mediterranean and a Norwegian setting.

The objective of this study was to investigate the sustained effect of a rehabilitation programme for patients with ankylosing spondylitis, and to compare the effect of this intervention given in a Mediterranean vs a Norwegian setting. A total of 107 patients with ankylosing spondylitis applying for rehabilitation were randomized to a 4-week inpatient rehabilitation programme in a Mediterranean country or in Norway. The participants were evaluated clinically before and after the rehabilitation period (week 0 and 4) and in week 16. The ASsessments in Ankylosing Spondylitis working group’s Improvement Criteria (ASAS-IC), and tests of spinal mobility and physical capacity were used to measure treatment response. An ASAS20 improvement was still present at week 16 in 50% of the patients treated in a Mediterranean and 23% in a Norwegian centre (p = 0.006). The tests of spinal mobility, physical capacity, and almost all patient’s assessments of health status (ASAS-IC components) were still improved at week 16 after therapy in both climatic settings. While the improvements in physical capacity were comparable, the spinal mobility and ASAS-IC components improved more, and improvements were sustained longer, after rehabilitation in a Mediterranean setting.

Patients with ankylosing spondylitis benefit from a 4-week rehabilitation programme in Norway, but even more so from a similar programme in a Mediterranean setting.

A Y, Nordvåg BY, Stanghelle JK, Røisland M, Winther A, Pajunen PA, Garen T, Flatø B. Efficacy of rehabilitation for patients with ankylosing spondylitis: Comparison of a four-week rehabilitation programme in a Mediterranean and a Norwegian setting. J Rehabil Med. 2011 Apr 14;

Global Health Course

Global Health is fast becoming a priority of all health organisations. Get ahead of the curve, take part in this course and help improve health around the world.

Speak your mind

Your email will not be published.